Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
2008 · Neuro-Oncology · 382 citations
https://doi.org/10.1215/15228517-2008-090
B
Brett L. Carlson
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
267
Papers
5.1K
Citations
34
h-index
54
i10-index
Brett L. Carlson is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Glioma Diagnosis and Treatment & PARP inhibition in cancer therapy & DNA Repair Mechanisms. The author has an h-index of 34, co-authored 227 publications.
ORCID: 0000-0003-2460-3079Papers by this author
worksDelineation of<i>MGMT</i>Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
2015 · JNCI Journal of the National Cancer Institute · 120 citations
https://doi.org/10.1093/jnci/djv369
Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins
2016 · Cell Reports · 74 citations
https://doi.org/10.1016/j.celrep.2016.02.045
Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas
2020 · BMC Cancer · 29 citations
https://doi.org/10.1186/s12885-020-07694-4
Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628
2024 · Molecular Cancer Therapeutics · 3 citations
https://doi.org/10.1158/1535-7163.mct-24-0664
Vaccination with TMEV Xho1-OVA8 enhances tumor antigen-restricted CD8+ T cell responses in the CNS, delays tumor progression, and extends survival in mice bearing GL261-Quad gliomas.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0125565.g003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat